Literature DB >> 8054245

Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.

C Cazeneuve1, G Pons, E Rey, J M Treluyer, T Cresteil, G Thiroux, P D'Athis, G Olive.   

Abstract

1. Caffeine metabolism was studied in human liver microsomes from foetuses (n = 10), neonates (n = 10), infants (n = 9) and adults (n = 5). Caffeine and its metabolites, 1-3-7-trimethyluric acid, paraxanthine, theophylline and theobromine, were assayed by h.p.l.c. Methoxyresorufin-O-demethylase activity (MEROD) was determined and immunoquantifiable levels of CYP1A2 were measured. 2. The formation of the dimethylxanthines by N-3, N-7 or N-1-demethylation was significantly less in foetuses, neonates and infants than in adults, as shown previously in vivo. The formation of 1-3-7-trimethyluric acid (C-8-hydroxylation) was not significantly different between age groups. The production of total dimethylxanthines, paraxanthine and theophylline increased significantly with age within the neonate-infant group over at least the 0-300 day range (rs = 0.739, 0.667, 0.682, respectively). These data differ from those reported in vivo which suggested that N-3 and N-7-demethylations matured at about 120 days. The difference in maturational profiles of each metabolic pathway suggests that the reactions depend on different isoenzymes. The delay in the maturation of N-1 compared with N-3 and N-7-demethylation is in agreement with previous in vivo data. 3. In the neonate-infant group, only N-3-demethylation correlated with both MEROD activity (rs = 0.681; P < 0.05) and CYP1A2 microsomal concentration (rs = 0.454; P approximately 0.05), suggesting that, as in adults, this reaction depends on CYP1A2. 4. In the foetal samples, the production of total dimethylxanthines, paraxanthine and theobromine decreased significantly (rs = -0.879, -0.767, -0.708, respectively) with increasing gestational age.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054245      PMCID: PMC1364894          DOI: 10.1111/j.1365-2125.1994.tb05706.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Immunoquantification of epoxide hydrolase and cytochrome P-450 isozymes in fetal and adult human liver microsomes.

Authors:  T Cresteil; P Beaune; P Kremers; C Celier; F P Guengerich; J P Leroux
Journal:  Eur J Biochem       Date:  1985-09-02

3.  Identification of a cytochrome P-450 in human fetal liver related to glucocorticoid-inducible cytochrome P-450HLp in the adult.

Authors:  S A Wrighton; D T Molowa; P S Guzelian
Journal:  Biochem Pharmacol       Date:  1988-08-01       Impact factor: 5.858

4.  Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations.

Authors:  M Kitada; T Kamataki; K Itahashi; T Rikihisa; Y Kanakubo
Journal:  Biochem Pharmacol       Date:  1987-02-15       Impact factor: 5.858

5.  Variability in caffeine metabolism.

Authors:  D M Grant; B K Tang; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1983-05       Impact factor: 6.875

6.  Purification and properties of cytochrome P-450 from homogenates of human fetal livers.

Authors:  M Kitada; T Kamataki; K Itahashi; T Rikihisa; R Kato; Y Kanakubo
Journal:  Arch Biochem Biophys       Date:  1985-08-15       Impact factor: 4.013

7.  Biotransformation of caffeine by microsomes from human liver. Kinetics and inhibition studies.

Authors:  D M Grant; M E Campbell; B K Tang; W Kalow
Journal:  Biochem Pharmacol       Date:  1987-04-15       Impact factor: 5.858

8.  Maturation of caffeine N-demethylation in infancy: a study using the 13CO2 breath test.

Authors:  G Pons; J C Blais; E Rey; M Plissonnier; M O Richard; O Carrier; P d'Athis; C Moran; J Badoual; G Olive
Journal:  Pediatr Res       Date:  1988-06       Impact factor: 3.756

9.  Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.

Authors:  M E Campbell; D M Grant; T Inaba; W Kalow
Journal:  Drug Metab Dispos       Date:  1987 Mar-Apr       Impact factor: 3.922

10.  Maturation of caffeine metabolic pathways in infancy.

Authors:  O Carrier; G Pons; E Rey; M O Richard; C Moran; J Badoual; G Olive
Journal:  Clin Pharmacol Ther       Date:  1988-08       Impact factor: 6.875

View more
  21 in total

1.  Caffeine, selected metabolic gene variants, and risk for neural tube defects.

Authors:  Rebecca J Schmidt; Paul A Romitti; Trudy L Burns; Jeffrey C Murray; Marilyn L Browne; Charlotte M Druschel; Richard S Olney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-07

2.  Biotransformation of caffeine by cDNA-expressed human cytochromes P-450.

Authors:  H R Ha; J Chen; S Krahenbuhl; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

3.  Neonatal pharmacology: extensive interindividual variability despite limited size.

Authors:  Cuneyt Tayman; Maisa Rayyan; Karel Allegaert
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

Review 4.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

5.  [Current research status of drug therapy for apnea of prematurity].

Authors:  Chao Chen; Xian-Xiao Shu; Xiao-Yan Yang; Jing Shi; Jun Tang; De-Zhi Mu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

6.  In vitro Phase I- and Phase II-Drug Metabolism in The Liver of Juvenile and Adult Göttingen Minipigs.

Authors:  Els Van Peer; Frank Jacobs; Jan Snoeys; Jos Van Houdt; Ils Pijpers; Christophe Casteleyn; Chris Van Ginneken; Steven Van Cruchten
Journal:  Pharm Res       Date:  2017-01-17       Impact factor: 4.200

7.  Percutaneous drug absorption and administration.

Authors:  I Choonara
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747

8.  Hepatic Cytochrome P450 Activity, Abundance, and Expression Throughout Human Development.

Authors:  Natalie C Sadler; Premchendar Nandhikonda; Bobbie-Jo Webb-Robertson; Charles Ansong; Lindsey N Anderson; Jordan N Smith; Richard A Corley; Aaron T Wright
Journal:  Drug Metab Dispos       Date:  2016-04-15       Impact factor: 3.922

9.  Serum caffeine concentrations and short-term outcomes in premature infants of ⩽29 weeks of gestation.

Authors:  P Alur; V Bollampalli; T Bell; N Hussain; J Liss
Journal:  J Perinatol       Date:  2014-12-18       Impact factor: 2.521

Review 10.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.